T. Rowe Price Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62B | Buy |
|
|||||
|
2025
Q1 | $1.65B | Buy |
|
|||||
|
2024
Q4 | $328M | Buy |
|
|||||
|
2024
Q3 | $281M | Buy |
|
|||||
|
2024
Q2 | $195M | Buy |
|
|||||
|
2024
Q1 | $183M | Sell |
|
|||||
|
2023
Q4 | $229M | Buy |
|
|||||
|
2023
Q3 | $170M | Sell |
|
|||||
|
2023
Q2 | $241M | Buy |
|
|||||
|
2023
Q1 | $206M | Buy |
|
|||||
|
2022
Q4 | $207M | Buy |
|
|||||
|
2022
Q3 | $102M | Sell |
|
|||||
|
2022
Q2 | $127M | Sell |
|
|||||
|
2022
Q1 | $149M | Sell |
|
|||||
|
2021
Q4 | $198M | Sell |
|
|||||
|
2021
Q3 | $250M | Sell |
|
|||||
|
2021
Q2 | $360M | Sell |
|
|||||
|
2021
Q1 | $350M | Sell |
|
|||||
|
2020
Q4 | $373M | Sell |
|
|||||
|
2020
Q3 | $511M | Sell |
|
|||||
|
2020
Q2 | $681M | Sell |
|
|||||
|
2020
Q1 | $828M | Buy |
|
|||||
|
2019
Q4 | $712M | Sell |
|
|||||
|
2019
Q3 | $706M | Sell |
|
|||||
|
2019
Q2 | $818M | Buy |
|
|||||
|
2019
Q1 | $781M | Sell |
|
|||||
|
2018
Q4 | $840M | Sell |
|
|||||
|
2018
Q3 | $1.12B | Sell |
|
|||||
|
2018
Q2 | $1.15B | Sell |
|
|||||
|
2018
Q1 | $1.31B | Buy |
|
|||||
|
2017
Q4 | $1.24B | Sell |
|
|||||
|
2017
Q3 | $1.5B | Buy |
|
|||||
|
2017
Q2 | $1.06B | Buy |
|
|||||
|
2017
Q1 | $896M | Buy |
|
|||||
|
2016
Q4 | $914M | Sell |
|
|||||
|
2016
Q3 | $1.13B | Sell |
|
|||||
|
2016
Q2 | $1.4B | Sell |
|
|||||
|
2016
Q1 | $2.49B | Sell |
|
|||||
|
2015
Q4 | $3.97B | Buy |
|
|||||
|
2015
Q3 | $3.83B | Sell |
|
|||||
|
2015
Q2 | $5.07B | Sell |
|
|||||
|
2015
Q1 | $4.6B | Sell |
|
|||||
|
2014
Q4 | $4.86B | Sell |
|
|||||
|
2014
Q3 | $6.27B | Sell |
|
|||||
|
2014
Q2 | $5.55B | Sell |
|
|||||
|
2014
Q1 | $5.24B | Sell |
|
|||||
|
2013
Q4 | $5.85B | Buy |
|
|||||
|
2013
Q3 | $4.79B | Sell |
|
|||||
|
2013
Q2 | $4.02B | Buy |
|